Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec 15;102(12):1663-7.
doi: 10.1016/j.amjcard.2008.07.055.

Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians

Catherine Rahilly-Tierney  1 , Thomas S Bowman, Luc Djoussé, Howard D Sesso, J Michael Gaziano
Affiliations

Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians

Catherine Rahilly-Tierney et al. Am J Cardiol. .

Abstract

The association between change in high-density lipoprotein (HDL) cholesterol and risk of subsequent coronary heart disease (CHD) is unclear. Change in HDL cholesterol was calculated in a prospective cohort of 4,501 male physicians enrolled in the Physician's Health Study (PHS) I who had HDL cholesterol measured in 1982 and again approximately 14 years later. Subjects were divided into categories of those with a decrease (>or=-2.5 mg/dl), no change (change -2.5 to 2.5 mg/dl), a small increase of 2.5 to 12.5 mg/dl, or a large increase of >or=12.5 mg/dl. Cox proportional hazards was used to examine the association between change in HDL cholesterol and incident CHD (confirmed acute myocardial infarction or cardiac death). Hazard ratios (HRs) were adjusted for age, initial HDL cholesterol, diabetes mellitus, hypertension, non-HDL cholesterol, and history of cholesterol medication. Compared with subjects with a decrease in HDL cholesterol, multivariable-adjusted HRs for CHD were 0.66 (95% confidence interval [CI] 0.40 to 1.09) in subjects with no change, 0.56 (95% CI 0.35 to 0.89) for subjects with an increase of 2.5 to 12.5 mg/dl, and 0.43 (95% CI 0.23 to 0.83) for subjects with an HDL cholesterol increase >or=12.5 mg/dl. In conclusion, our findings were consistent with an inverse graded relation between 14-year increase in HDL cholesterol and risk of subsequent CHD.

PubMed Disclaimer

References

    1. The Steering Committee of the Physician's Health Study Research Group. Belanger C, Buring JE, Cook N, Aberlein K, Goldhaber SZ, Gordon D, Hennekins CH, Mayrent SL, Peto R, Rosner B, Stampfer M, Stubbefield F, Willett W. Final report on the aspirin component of the ongoing Physician's Health Study. New Engl J Med. 1989;10:1425–1505.
    1. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, Lamotte R, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta-carotene on incidence of malignant neoplasms and cardiovascular disease. New Engl J Med. 1996;334:1145–1149. - PubMed
    1. Sesso HD, Gaziano JM, VanDenBurgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants an non-participants in a randomized clinical trial: the Physician's Health Study. Control Clin Trials. 2002;23:686–702. - PubMed
    1. Scranton R, Sesso HD, Stampfer MJ, Levenson JW, Buring JE, Gaziano JM. Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men. Am H J. 2004;147:1033–1038. - PubMed
    1. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham study. J Gerontol. 1994;49:M252–M257. - PubMed

Publication types

Substances